Thyroid storm is an extreme and potentially fatal form of thyrotoxicosis, characterized by a sudden amplification of the systemic effects of thyroid hormones on the cardiovascular system, central nervous system, and energy metabolism. It is not simply a biochemically more severe form of hyperthyroidism, but a condition of acute systemic dysregulation in which the body loses its ability to compensate for hormone excess, resulting in rapid clinical deterioration. The event almost always occurs in patients with known or undiagnosed hyperthyroidism who are exposed to a precipitating factor that acts as a trigger in the setting of unstable endocrine function.
From a clinical perspective, thyroid storm is a true medical emergency. Mortality remains significant even in highly specialized centers, despite advances in intensive care, because the condition combines refractory tachyarrhythmias, acute heart failure, hyperthermia, neurological abnormalities, and multiorgan dysfunction. Diagnosis is primarily clinical and must be established rapidly, without waiting for complete laboratory confirmation, because time is a critical determinant of outcome.
Thyroid storm is rare compared with uncomplicated hyperthyroidism, but its clinical relevance is disproportionate to its frequency because of its high mortality and its impact on healthcare resources. Most cases occur in patients with untreated or inadequately treated Graves disease, but the crisis may also develop in the setting of toxic multinodular goiter, toxic adenoma, or iatrogenic thyrotoxicosis. It is not uncommon for the event to represent the first recognized manifestation of underlying thyrotoxicosis, particularly in individuals who have never undergone an endocrinological evaluation.
The epidemiology is strongly influenced by the presence of acute precipitating factors. Systemic infections, major cardiovascular events, surgery, trauma, abrupt discontinuation of antithyroid therapy, or excessive iodine exposure are the most common triggers. In cardiology settings, thyroid storm may occur in patients with complex arrhythmias or heart failure, in whom acute hormone excess acts as a destabilizing factor in an already compromised heart.
From a demographic perspective, the condition is more frequent in women, in line with the epidemiology of autoimmune hyperthyroidism, but in men it tends to present with more severe manifestations and to be diagnosed later. Advanced age is an additional risk factor for a severe course because cardiac and metabolic functional reserves are reduced and the classic signs may be less evident, contributing to delayed diagnosis.
The reduction in incidence observed in recent decades in countries with widespread access to diagnosis and treatment should not lead clinicians to underestimate thyroid storm. In settings where treatment adherence is irregular or major comorbidities coexist, the crisis remains a real possibility, and clinicians must maintain a high level of vigilance in thyrotoxic patients exposed to acute stress.
Thyroid storm results from a synergistic interaction between thyroid hormone excess and precipitating factors that amplify the systemic response. From an etiological perspective, the underlying condition is always pre-existing thyrotoxicosis, even when undiagnosed, upon which an acute event is superimposed that increases hormone availability or activity at the tissue level. This may occur through increased hormone release, enhanced peripheral sensitivity, or impairment of compensatory mechanisms.
At the molecular and cellular levels, thyroid hormones increase beta-adrenergic receptor expression and enhance catecholaminergic signal transduction. During thyroid storm, this effect becomes massive, causing extreme tachycardia, increased myocardial contractility, and increased oxygen consumption, with a risk of ischemia and heart failure. At the same time, excess T3 accelerates mitochondrial metabolism and heat production, contributing to hyperthermia and increased energy requirements, which may exceed the body’s compensatory capacity.
Precipitating factors act as amplifiers. A systemic infection increases the release of proinflammatory cytokines, which enhance thyroid hormone activity and disrupt central temperature regulation. Surgery or trauma activates the stress response, increasing circulating catecholamines and reducing hormone clearance. Abrupt discontinuation of antithyroid treatment removes an essential pharmacological restraint, whereas an iodine load may rapidly increase hormone synthesis or release in an already hyperfunctioning thyroid gland.
The pathophysiology of the crisis also involves the central nervous system, where hormone excess alters neurotransmission and cerebral metabolism, causing agitation, delirium, and, in the most severe cases, coma. At the hepatic level, increased metabolism and congestion secondary to heart failure may lead to liver dysfunction, which in turn reduces the clearance of hormones and medications, creating a vicious cycle. The final result is multiorgan dysfunction sustained by endocrine and metabolic hyperstimulation that can no longer be controlled without intensive therapeutic intervention.
The clinical presentation of thyroid storm is dramatic and multisystemic. The classic presentation includes hyperthermia, severe tachycardia or arrhythmias, altered mental status, and signs of cardiac or circulatory failure. Fever is often high and resistant to common antipyretics because it is driven by an intrinsic increase in thermogenesis rather than by an isolated infectious mechanism. Tachycardia may progress to rapid atrial fibrillation or ventricular tachyarrhythmias, with hemodynamic instability.
Neurological manifestations range from agitation and marked anxiety to delirium, acute psychosis, seizures, and coma. These signs reflect the direct effects of thyroid hormones on cerebral metabolism and neurotransmission, but they are aggravated by hyperthermia, hypoxia, and electrolyte disturbances. Gastrointestinal manifestations, including nausea, vomiting, and diarrhea, are common and contribute to dehydration and fluid and electrolyte imbalances, further worsening the hemodynamic condition.
The cardiovascular system is the principal determinant of prognosis. In addition to tachycardia, signs of acute heart failure, pulmonary edema, and hypotension caused by exhaustion of contractile reserve may develop. In patients with pre-existing heart disease, even a short period of hyperstimulation may cause significant damage. The skin appears warm, flushed, and sweaty, while weight loss may be rapid when the crisis develops after a period of unrecognized thyrotoxicosis.
It is important to emphasize that not all signs must be present simultaneously. Particularly in older adults, thyroid storm may present with an “atypical” phenotype in which heart failure and altered mental status predominate, with less evident fever. This makes a comprehensive clinical assessment essential, rather than a rigid search for a stereotyped presentation.
Thyroid storm should be suspected immediately in any patient with known or suspected hyperthyroidism who develops an acute and disproportionate deterioration in clinical status, particularly in the presence of a recent precipitating factor. High fever associated with tachyarrhythmia, altered mental status, or heart failure represents a highly suggestive combination that requires the diagnosis to be considered even before laboratory results become available.
Suspicion should also be high in patients without a previous endocrinological diagnosis who have compatible clinical signs and a suggestive medical history, such as weight loss, heat intolerance, and palpitations during the preceding months, followed by an acute event such as infection or surgery. In these cases, the most dangerous error is to attribute the presentation exclusively to the trigger, thereby delaying recognition of the underlying thyrotoxic crisis.
Another critical setting is the abrupt discontinuation of antithyroid therapy or poor treatment adherence, which may precipitate a crisis in previously compensated patients. In the presence of these features, clinical suspicion should be sufficient to initiate treatment immediately, because waiting for formal confirmation may result in irreversible deterioration.
The diagnosis of thyroid storm is clinical and is based on the integration of signs, symptoms, and clinical context rather than on absolute laboratory thresholds. Laboratory tests typically show suppressed TSH with elevated FT4 and FT3, but hormone levels are not necessarily higher than those observed in uncomplicated hyperthyroidism. What distinguishes the crisis is the severity of the systemic response, not the isolated biochemical finding.
Clinical scoring systems have been proposed to support diagnosis and severity stratification. Among these, the Burch-Wartofsky score incorporates body temperature, cardiovascular, neurological, and gastrointestinal manifestations, as well as the presence of precipitating factors. Although it does not replace clinical judgment, this tool helps standardize assessment and strengthen diagnostic suspicion in borderline situations.
Instrumental investigations are primarily directed toward evaluating complications and precipitating factors. An ECG is essential to identify arrhythmias and guide cardiovascular management. Comprehensive blood tests allow assessment of liver and kidney function, inflammatory status, and electrolyte balance. Detailed thyroid etiological investigations, such as imaging or autoantibody testing, may be postponed until the patient has been stabilized because they must not delay lifesaving treatment.
In summary, diagnosis is based on a high clinical probability and the need for rapid intervention. In the presence of a compatible presentation, it is preferable to treat the patient as having thyroid storm rather than wait for confirmation, because the risk of overtreatment is lower than the risk associated with delayed treatment.
The treatment of thyroid storm is a medical emergency requiring a multimodal and sequential approach, ideally in an intensive care unit or high-dependency setting. There are four objectives: to block thyroid hormone synthesis, inhibit the release of preformed hormones, counteract the peripheral effects of thyroid hormones, and treat the precipitating factor. These interventions must be initiated in rapid succession and often in parallel.
The first cornerstone is the administration of antithyroid medications to block hormone synthesis, typically propylthiouracil or methimazole, while taking into account their specific pharmacological characteristics and the available route of administration. Immediately afterward, inorganic iodine is administered to inhibit the release of preformed hormones, while respecting the correct timing to avoid providing additional substrate for hormone synthesis. At the same time, beta-blockers are essential for controlling tachycardia and reducing peripheral adrenergic effects.
Glucocorticoids play a crucial role because they reduce the peripheral conversion of T4 to T3 and treat possible relative adrenal insufficiency induced by stress. Intensive supportive care includes temperature control using physical cooling measures, fluid and electrolyte management, and ventilatory or hemodynamic support when necessary. Treatment of the precipitating factor, such as antibiotics for infection or management of an acute cardiac event, is an integral part of the strategy and cannot be postponed.
In cases refractory to medical treatment, or when control cannot be achieved within a timeframe compatible with the patient’s stability, emergency thyroidectomy may represent a lifesaving option when it can be performed in an experienced center. This decision requires a rigorous assessment of perioperative risk, but it may be decisive when all other measures prove insufficient.
Follow-up after thyroid storm is a critical phase of patient care. Once the acute phase has resolved, thyroid function must be definitively stabilized to prevent recurrence. This may require transition to definitive treatment with radioiodine or surgery, depending on the underlying etiology, comorbidities, and clinical considerations. Simply resuming antithyroid therapy is not always sufficient because the risk of another crisis persists if stable control is not achieved.
Prognosis is closely related to the speed of diagnosis and therapeutic intervention. Despite advances in treatment, mortality remains significant, particularly in older patients or those with advanced heart disease. However, in patients treated early and managed intensively, recovery may be complete, with full restoration of neurological and cardiovascular function.
Long-term follow-up should include regular endocrinological monitoring, cardiovascular assessment, and patient education regarding the importance of treatment adherence and early recognition of symptoms of thyrotoxic decompensation. Thyroid storm is a sentinel event that indicates the need for definitive and rigorous endocrine management to prevent recurrence of a life-threatening condition.